The difference between the CK19-2G2 serum levels of the adenocarcinoma and squamous cell carcinoma patients was not statistically significant (8.21±6.57 vs. 10.83±14.30, P = 0.252). This evidence concerns the gene KRT19 and adenocarcinoma.